Acquisitions

The Harsh Goenka group is spending to build a drug-ingredients business, betting that the world's push to rely less on China will favour Indian makers.

Arcil has identified collections-as-a-service as a new business vertical in its draft red herring prospectus for its IPO

India Inc’s record shows why companies that pursue inorganic growth must also strengthen innovation, technology, talent and operational excellence. Integration is where value gets created when scaling up rapidly through acquisitions.

India now has six real estate investment trusts—five in office and one in retail—backed by global asset managers such as Blackstone and Brookfield, and leading office developers.

Indian PE funds holding mature, older-vintage assets are turning to secondary sales, sponsor-to-sponsor buyouts and continuation vehicles as IPO-led exits fall 47% and limited partner pressure to improve distributed-to-paid-in capital mounts.

Goldman Sachs has appointed former JPMorgan executive Chandresh Chheda as managing director and co-head of India investment banking. His appointment comes as India’s IPO, ECM and M&A markets remain strong, with Goldman expanding its dealmaking franchise.

The acquisition marks ChrysCapital's first majority-controlled investment in the Indian pharmaceutical sector.

Wolfe Research Chief Investment Strategist Chris Senyek and his team run monthly screens to identify possible targets.